Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Accumulated Expenses: 2023-2024

Historic Accumulated Expenses for Camp4 Therapeutics (CAMP) over the last 2 years, with Dec 2024 value amounting to $4.8 million.

  • Camp4 Therapeutics' Accumulated Expenses rose 10.55% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year increase of 10.55%. This contributed to the annual value of $4.8 million for FY2024, which is 46.37% up from last year.
  • Latest data reveals that Camp4 Therapeutics reported Accumulated Expenses of $4.8 million as of FY2024, which was up 46.37% from $3.3 million recorded in FY2023.
  • In the past 5 years, Camp4 Therapeutics' Accumulated Expenses ranged from a high of $4.8 million in FY2024 and a low of $3.3 million during FY2023.
  • In the last 2 years, Camp4 Therapeutics' Accumulated Expenses had a median value of $4.1 million in 2023 and averaged $4.1 million.
  • Data for Camp4 Therapeutics' Accumulated Expenses shows a peak YoY soared of 46.37% (in 2024) over the last 5 years.
  • Camp4 Therapeutics' Accumulated Expenses (Yearly) stood at $3.3 million in 2023, then surged by 46.37% to $4.8 million in 2024.